Lightweight and portable

Weighing just 5kg, the device can be easily transported and operated, reaching remote locations and communities with limited access to health facilities.

Battery operated

The device runs without electricity, ideal for underserved locations where power supply is unreliable or unavailable.

More affordable

Now available to eligible buyers in 138 low- and middle-income countries at a significantly reduced cost compared to other devices of similar quality.

AI-compatible

Compatible with artificial intelligence software that helps interpret scans quickly and accurately, supporting early diagnosis and faster access to care, even in areas without trained radiologists.

Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, yet many people – especially in rural or remote communities – go undiagnosed each year. Early diagnosis is essential to stop transmission and ensure people receive timely care.  

Chest X-rays offer a fast, non-invasive way to screen for signs of TB in the lungs, but they’re often out of reach for people living in remote settings. This ultraportable device helps brings TB screening closer to these communities.  

When paired with artificial intelligence, they can provide accurate results without requiring trained radiologists – making them a vital tool for early detection and improved TB care in underserved communities. 

Unitaid has secured a pricing agreement to significantly lower the price of these devices and is supporting their roll-out in low- and middle-income countries. Through strategic partnerships, we’re helping make this lifesaving technology more accessible – bringing quality TB screening closer to the communities that need it most. 

Related projects
Related news